Encompass Health Reaffirms Full-Year 2025 Guidance; Net Operating Revenue Of $5.905B-$5.955B; Adjusted EBITDA Of $1.235B-$1.255B; Adjusted EPS From Continuing Operations Attributable To Encompass Health Of $5.22-$5.37

Members of Encompass Health Corporation's (the "Company" or "Encompass Health") senior management team are scheduled to meet with investors and analysts at various meetings on December 2, 2025 and December 3, 2025.

The Company reiterates as of the date hereof its guidance previously reported in the Current Report on Form 8-K, dated October 29, 2025, and during the Company's earnings conference call held on October 30, 2025. Accordingly, the Company continues to expect the following full-year 2025 ranges:

•Net operating revenue of $5,905 million to $5,955 million;

•Adjusted EBITDA of $1,235 million to $1,255 million; and

•Adjusted earnings per share from continuing operations attributable to Encompass Health of $5.22 to $5.37.